Senators
press Mylan on
?exorbitantly expensive? EpiPen
WASHINGTON (Reuters) – Democrat Elizabeth Warren and 19 other U.S.
Senators voiced concern to the chief executive of
Mylan NV about the high cost of its
EpiPen on Tuesday, calling the device used in the case of life-threatening allergies “exorbitantly expensive.”
